Education
About Us
Working with TipRanks
Follow Us
Galera Therapeutics, Inc. (GRTX)
:GRTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -3.84M | $ -259.00K | $ -114.00K | $ -778.00K | $ -368.00K |
| Operating Income | $ -20.16M | $ -46.95M | $ -51.23M | $ -73.37M | $ -70.55M |
| EBITDA | $ -20.16M | $ -46.69M | $ -50.61M | $ -72.56M | $ -69.01M |
| Net Income | $ -18.96M | $ -59.08M | $ -62.22M | $ -80.53M | $ -74.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.29M | $ 18.26M | $ 31.60M | $ 71.22M | $ 72.78M |
| Total Assets | $ 10.10M | $ 26.14M | $ 44.04M | $ 83.31M | $ 84.10M |
| Total Debt | $ 0.00 | $ 1.25M | $ 44.00K | $ 302.00K | $ 534.00K |
| Net Debt | $ -8.29M | $ -17.01M | $ -4.22M | $ -19.56M | $ -15.34M |
| Total Liabilities | $ 153.77M | $ 157.33M | $ 153.22M | $ 141.31M | $ 77.98M |
| Stockholders' Equity | $ -143.67M | $ -131.19M | $ -109.18M | $ -58.00M | $ 6.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.14M | $ -44.91M | $ -43.45M | $ -68.24M | $ -59.99M |
| Operating Cash Flow | $ -12.14M | $ -44.85M | $ -43.43M | $ -67.96M | $ -59.54M |
| Investing Cash Flow | $ -46.00K | $ 27.29M | $ 23.99M | $ 5.24M | $ 36.55M |
| Financing Cash Flow | $ 2.22M | $ 31.50M | $ 3.89M | $ 66.71M | $ 20.51M |